3β-Sulfamate Derivatives of C19 and C21 Steroids Bearing a t -Butylbenzyl or a Benzyl Group: Synthesis and Evaluation as Non-estrogenic and Non-androgenic Steroid Sulfatase Inhibitors

A series of C19 and C21 steroids bearing one or two inhibiting groups (3 β -sulfamate and 17 α - or 20(S)- t -butylbenzyl or benzyl) were synthesized and tested for inhibition of steroid sulfatase activity. When only a sulfamate group was added to dehydroepiandrosterone, androst-5-ene-3 β,17 β -diol...

Full description

Saved in:
Bibliographic Details
Published inJournal of enzyme inhibition and medicinal chemistry Vol. 18; no. 1; pp. 15 - 26
Main Authors Ciobanu, Liviu C., Boivin, Roch P., Luu-The, Van, Poirier, Donald
Format Journal Article
LanguageEnglish
Published Informa UK Ltd 01.01.2003
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A series of C19 and C21 steroids bearing one or two inhibiting groups (3 β -sulfamate and 17 α - or 20(S)- t -butylbenzyl or benzyl) were synthesized and tested for inhibition of steroid sulfatase activity. When only a sulfamate group was added to dehydroepiandrosterone, androst-5-ene-3 β,17 β -diol, pregnenolone and 20-hydroxy-pregnenolone, no significant inhibition of steroid sulfatase occurred at concentrations of 0.3 and 3 μM. With only a t -butylbenzyl or a benzyl group, a stronger steroid sulfatase inhibition was obtained in the androst-5-ene than in the pregn-5-ene series. Comparative results from the screening tests and the IC 50 values have shown that the effect of a sulfamate moiety as a second inhibiting group can be combined to the t -butylbenzyl or benzyl effect in the C19 and C21 steroid series. The 3 β -sulfamoyloxy-17 α - t -butylbenzyl-5-androsten-17 β -ol (10) was thus found to be the most active compound with IC 50 values of 46 ± 8 and 14 ± 1 nM, respectively for the transformations of E 1 S to E 1 and DHEAS to DHEA. The IC 50 values of compound 10 are similar to that of 17 α - t -butylbenzyl-estradiol, which was previously reported by our group as a good steroid sulfatase reversible inhibitor, but remains higher than that of the potent inactivators estrone-3- O -sulfamate (EMATE) and 17 α - t -butylbenzyl-EMATE. However, contrary to these two latter inhibitors, compound 10 did not induce any proliferative effect on estrogen-sensitive ZR-75-1 cells nor on androgen-sensitive Shionogi cells at concentrations tested, suggesting that this steroid sulfatase inhibitor is non estrogenic and non androgenic.
AbstractList A series of C19 and C21 steroids bearing one or two inhibiting groups (3 β -sulfamate and 17 α - or 20(S)- t -butylbenzyl or benzyl) were synthesized and tested for inhibition of steroid sulfatase activity. When only a sulfamate group was added to dehydroepiandrosterone, androst-5-ene-3 β,17 β -diol, pregnenolone and 20-hydroxy-pregnenolone, no significant inhibition of steroid sulfatase occurred at concentrations of 0.3 and 3 μM. With only a t -butylbenzyl or a benzyl group, a stronger steroid sulfatase inhibition was obtained in the androst-5-ene than in the pregn-5-ene series. Comparative results from the screening tests and the IC 50 values have shown that the effect of a sulfamate moiety as a second inhibiting group can be combined to the t -butylbenzyl or benzyl effect in the C19 and C21 steroid series. The 3 β -sulfamoyloxy-17 α - t -butylbenzyl-5-androsten-17 β -ol (10) was thus found to be the most active compound with IC 50 values of 46 ± 8 and 14 ± 1 nM, respectively for the transformations of E 1 S to E 1 and DHEAS to DHEA. The IC 50 values of compound 10 are similar to that of 17 α - t -butylbenzyl-estradiol, which was previously reported by our group as a good steroid sulfatase reversible inhibitor, but remains higher than that of the potent inactivators estrone-3- O -sulfamate (EMATE) and 17 α - t -butylbenzyl-EMATE. However, contrary to these two latter inhibitors, compound 10 did not induce any proliferative effect on estrogen-sensitive ZR-75-1 cells nor on androgen-sensitive Shionogi cells at concentrations tested, suggesting that this steroid sulfatase inhibitor is non estrogenic and non androgenic.
Author Ciobanu, Liviu C.
Poirier, Donald
Luu-The, Van
Boivin, Roch P.
Author_xml – sequence: 1
  givenname: Liviu C.
  surname: Ciobanu
  fullname: Ciobanu, Liviu C.
  organization: Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec (CHUQ--Pavillon CHUL) 2705 Boulevard Laurier and Laval University, Québec, Qc., G1V 4G2, Canada
– sequence: 2
  givenname: Roch P.
  surname: Boivin
  fullname: Boivin, Roch P.
  organization: Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec (CHUQ--Pavillon CHUL) 2705 Boulevard Laurier and Laval University, Québec, Qc., G1V 4G2, Canada
– sequence: 3
  givenname: Van
  surname: Luu-The
  fullname: Luu-The, Van
  organization: Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec (CHUQ--Pavillon CHUL) 2705 Boulevard Laurier and Laval University, Québec, Qc., G1V 4G2, Canada
– sequence: 4
  givenname: Donald
  surname: Poirier
  fullname: Poirier, Donald
  organization: Medicinal Chemistry Division, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec (CHUQ--Pavillon CHUL) 2705 Boulevard Laurier and Laval University, Québec, Qc., G1V 4G2, Canada
BookMark eNp9kNtOGzEQhq2KSuXQJ-iNX2BbHzZegwQSSTlJCC5Cr1eTzZgYbWw09gZtH4srnoJnYpPQSpUq5uYf_Zr5PP732E6IARn7JsV3Kaz4IctqZLQRWoqhzKGy6hPbXbuF0VW587c35gvbS-lBCCWVLHfZi359LqZd62AJGflPJL-C7FeYeHR8Ig85hDmfKMmnGSn6eeJjBPLhngPPvBh3uW9nGH73LY80eONtf0Gxezzi0z7kBSafNpizFbTdQI-BQ-I3MRSYMsV7DL7ZDKytQf9Y70_yzX0ZEvKrsPAznyOlA_bZQZvw67vus1_nZ3eTy-L69uJqcnpdNFoaVeBaNLqqQqu0mFczNaosggApnMMSrZFQSt1UdkgKnbEKbNnYalQq0Vip95nechuKKRG6-pH8EqivpajX4df_CX_YOtlu-eAiLeEpUjuvM_RtJEcQGp9q_THg-B_AAqHNiwYI64fYURi-_OEBb3O6oTw
CitedBy_id crossref_primary_10_1517_13543776_15_11_1541
crossref_primary_10_1016_j_bmc_2020_115368
crossref_primary_10_1016_j_mce_2013_06_022
crossref_primary_10_1080_00304940609355990
crossref_primary_10_1021_cc020115u
crossref_primary_10_1016_j_bmcl_2004_07_013
crossref_primary_10_1016_j_bmcl_2016_09_046
crossref_primary_10_1016_j_ejmech_2016_04_044
crossref_primary_10_1016_j_mce_2010_12_035
crossref_primary_10_1016_j_ejmech_2016_02_054
crossref_primary_10_1016_j_jsbmb_2005_02_007
crossref_primary_10_1021_acsmedchemlett_7b00265
crossref_primary_10_1021_cr400230c
crossref_primary_10_1016_j_steroids_2012_07_012
crossref_primary_10_1016_j_steroids_2011_03_010
crossref_primary_10_1016_j_jsbmb_2018_05_009
crossref_primary_10_1210_er_2004_0003
crossref_primary_10_1016_j_ejmech_2019_05_023
crossref_primary_10_1016_j_jsbmb_2013_01_013
crossref_primary_10_1002_med_20008
crossref_primary_10_1016_j_steroids_2021_108856
ContentType Journal Article
Copyright 2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003
Copyright_xml – notice: 2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003
DBID AAYXX
CITATION
DOI 10.1080/1475636031000069282
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1475-6374
EndPage 26
ExternalDocumentID 10_1080_1475636031000069282
11202746
Genre Research Article
GroupedDBID ---
00X
0R~
0YH
29K
36B
4.4
53G
5GY
5VS
7X7
8FI
8FJ
A8Z
AALIY
ABDBF
ABPTK
ABUWG
ACGEJ
ACGFS
ADBBV
ADCVX
ADRBQ
ADXPE
AENEX
AEYQI
AFKRA
AFKVX
AJWEG
ALIIL
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ARJSQ
AWYRJ
BABNJ
BCNDV
BENPR
BPHCQ
BVXVI
CAG
COF
CS3
CZDIS
D-I
DRXRE
DU5
DWTOO
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
EST
ESX
F5P
FYUFA
GROUPED_DOAJ
H13
HYE
HZ~
KRBQP
KWAYT
M44
M4Z
O9-
OK1
P2P
PIMPY
PQEST
PQQKQ
PQUKI
PROAC
RPM
SV3
TFDNU
TFL
TFW
TUS
UKHRP
V1S
~1N
AAYXX
ALIPV
CCPQU
CITATION
ESTFP
HMCUK
NUSFT
TDBHL
ID FETCH-LOGICAL-c3162-ec3163ef77e8230d7b2578ea0a10ffe4e861a413c78637ef682a84c875420c813
IEDL.DBID 0YH
ISSN 1475-6366
IngestDate Fri Aug 23 01:01:30 EDT 2024
Thu Sep 08 17:34:44 EDT 2022
Wed Jun 21 08:14:46 EDT 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3162-ec3163ef77e8230d7b2578ea0a10ffe4e861a413c78637ef682a84c875420c813
OpenAccessLink https://www.tandfonline.com/doi/pdf/10.1080/1475636031000069282?needAccess=true
PageCount 12
ParticipantIDs informahealthcare_journals_10_1080_1475636031000069282
crossref_primary_10_1080_1475636031000069282
informaworld_taylorfrancis_310_1080_1475636031000069282
PublicationCentury 2000
PublicationDate 1/1/2003
PublicationDateYYYYMMDD 2003-01-01
PublicationDate_xml – month: 01
  year: 2003
  text: 1/1/2003
  day: 01
PublicationDecade 2000
PublicationTitle Journal of enzyme inhibition and medicinal chemistry
PublicationYear 2003
Publisher Informa UK Ltd
Taylor & Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
SSID ssj0021214
Score 1.7839681
Snippet A series of C19 and C21 steroids bearing one or two inhibiting groups (3 β -sulfamate and 17 α - or 20(S)- t -butylbenzyl or benzyl) were synthesized and...
SourceID crossref
informaworld
informahealthcare
SourceType Aggregation Database
Publisher
StartPage 15
SubjectTerms C19 Steroid
C21 Steroid
Estrogen
Inhibitor
Sulfamate
Sulfatase
Title 3β-Sulfamate Derivatives of C19 and C21 Steroids Bearing a t -Butylbenzyl or a Benzyl Group: Synthesis and Evaluation as Non-estrogenic and Non-androgenic Steroid Sulfatase Inhibitors
URI https://www.tandfonline.com/doi/abs/10.1080/1475636031000069282
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEBZpcsmlpE1D0z_mUHKqiGV5JTu37DZhW0gu20ByMpI9IoatXdbewvaxcupT9Jk6kr1L2oYcerIRHttoRvpmRsM3jL0vMROhzs8iJjzJYseNGBkupVKWHAihQh-yi0s1vUo-X4-uhz6n7VBW6WNo1xNFhL3aL25j23VF3LFI9MjTXPW5aZVR1PCE7cSasJ8MOrqZbiIuEQdyby_ASUKtaYcefskf0LQ3EJfebsqw_iIzvQdD53vs6eA_wmmv8GdsC-vnbP-0ptj56wqOIFR0hlT5Pvspf93x2XLuDLmlCB_J2L4Hnu8WGgcTkQFNAUxiATOa3aYqWxiT4ROYgYEO-HjZreYW6x-rOTQLGhv39yFfdQKzVU3eY1u14TVnG9pwMC1cNjUnvFk0ZJ9VER7wQ8bTI_RDwych_F9HWAqf6tvKVr77zwt2dX72ZTLlQ6cGXkihYo7-ItFpjf7grtTW7wRoIiMi5zDBVAlDcFnoVEmNTqWxSZMi9e13oyIV8oBt102NLxnEBZYmK3VpXTjTzRCdjaxMEyNcnOEh-7BWUv6tJ-TIxcBz-oBOD5n6R5H5sEzbxwX1fW3nXUiguL7bSS4fkXz135Kv2W6oFQwZnjdsu1ss8S35PJ19F-z6N19K90Q
link.rule.ids 315,783,787,27514,27936,27937,59471,59472,61546,61547
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwELYoHOgFUWhV6A9zqHqq1TjO2klv7Ba0tLCXBQlOkZ2MRaRtUm2ylZbH4sRT8Ey1nexqC4hDT4lGGSfyjD0_nnxDyKccE-br_DRiRKMkNFSxnqKcC6GtA8GE70N2NhLDi-jHZe9y5S9-V1bpYmjTAkX4vdotbpeMXpTEfWWR7DmcqzY5LRIbNrwgG70kkq6HQXA1XIZcLPTo3o6BWg6xwB16epB_bNN2h1x6vazDeoBmumKHjrfJVudAwmEr8VdkDcsdsntY2uD51xw-gy_p9LnyXXLH72_peDYxyvqlCN-ttv3xQN81VAYGLAE7BzAIGYzt9FZFXkPfar61ZqCgAdqfNfOJxvJmPoFqamn99t4nrL7BeF5a97Euaj_M0RI3HFQNo6qk1uBMK6ugReYfcCTl8BFaUvdK8N_XWGMKJ-V1oQvX_uc1uTg-Oh8MadeqgWaciZCiu3A0UqI7uculdlsBqkCxwBiMMBZMWXuZyVhwiUbEoYqjLHb9d4MsZvwNWS-rEt8SCDPMVZLLXBt_qJsgGh1oHkeKmTDBPfJlIaT0d4vIkbIO6PQJme4R8UiQabdO6-cZ5aq008ZnUEzb7iTlz3Du_zfnAdkcnp-dpqcno5_vyEtfOOjTPe_JejOd4QfrADX6o9fxv8t1-rQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELagSIgLKhREgZY5IE5YxHHWSbh1t11t-VkhLZXKKbKTsRppSapNFml5rJ76FDwTYye7Km3VA6dEVsaxPOP58-gbxt4WmApf52cQIx6loeVaDDSXUilDDoRQvg_Z16manESfTgenfZ_Tpi-rdDG07YAivK52h_u8sOuKuA8iigcO5qrLTauUoob77MEgJT1LAh38mGwiLhF6cG9HwIlCrWGHbp_kH9O03QOXnm3KsK6BmV4xQ-Nt9rj3H-GgY_gTdg-rp2znoKLY-ecK3oGv6PSp8h12Kf9c8NlybjW5pQiHJGy_PM53A7WFkUiBtgBGoYAZ7W5dFg0MSfDJmIGGFvhw2a7mBqvfqznUCxobdu8-X_URZquKvMembPw0RxvYcNANTOuKk71Z1CSfZe4_cEPawSN0Q_0vwa-vJVsKx9VZaUrX_ecZOxkffR9NeN-pgedSqJCje0i0cYzu4q6IjdMEqAMtAmsxwkQJTeYyjxMlY7QqCXUS5YlrvxvkiZDP2VZVV_iCQZhjodMiLoz1d7opojWBkUmkhQ1T3GXv10zKzjtAjkz0OKe38HSXqRuMzPpj2txNGF_ldtb6BIrtup1k8g7Kl_9N-YY9_HY4zr4cTz-_Yo982aBP9rxmW-1iiXvk_rRm34v4Xzn4-d0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=3%CE%B2-Sulfamate+Derivatives+of+C19+and+C21+Steroids+Bearing+a+t+-Butylbenzyl+or+a+Benzyl+Group%3A+Synthesis+and+Evaluation+as+Non-estrogenic+and+Non-androgenic+Steroid+Sulfatase+Inhibitors&rft.jtitle=Journal+of+enzyme+inhibition+and+medicinal+chemistry&rft.au=Ciobanu%2C+Liviu+C.&rft.au=Boivin%2C+Roch+P.&rft.au=Luu-The%2C+Van&rft.au=Poirier%2C+Donald&rft.date=2003-01-01&rft.pub=Taylor+%26+Francis&rft.issn=1475-6366&rft.eissn=1475-6374&rft.volume=18&rft.issue=1&rft.spage=15&rft.epage=26&rft_id=info:doi/10.1080%2F1475636031000069282&rft.externalDocID=11202746
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-6366&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-6366&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-6366&client=summon